Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05NCT05387083TARSPhase 2Completed2024-06-26Actual
A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)NCT05392114IONSPhase 3Active not recruiting2026-12Estimated
A Study in Subjects With Retinitis PigmentosaNCT05392179ALDXPhase 2Completed2023-06-23Actual
A Clinical Trial to Evaluate the Safety and Efficacy in Subjects With Chronic CoughNCT05392192ALDXPhase 2Completed2023-04-13Actual
Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)NCT05397470Fulcrum TherapeuticsPhase 3Terminated2024-11-19Actual
Ibrexafungerp for the Treatment of Complicated Vulvovaginal CandidiasisNCT05399641SCYXPhase 3Completed2023-05-16Actual
A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver FibrosisNCT05402371Hepion Pharmaceuticals, Inc.Phase 2Unknown2025-05Estimated
A Study of CDX-0159 in Patients With Chronic Inducible UrticariaNCT05405660Celldex TherapeuticsPhase 2Completed2024-06-12Actual
A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety SymptomsNCT05407064Definium Therapeutics US, Inc.Phase 2Completed2023-10-06Actual
Dazucorilant in Patients With Amyotrophic Lateral SclerosisNCT05407324Corcept TherapeuticsPhase 2Active not recruiting2026-10Estimated
Study of ARO-APOC3 in Adults With DyslipidemiaNCT05413135Arrowhead PharmaceuticalsPhase 2Completed2025-09-22Actual
Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary SarcoidosisNCT05415137ATYRPhase 3Completed2025-06-25Actual
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)NCT05416307ETRAPhase 2, Phase 3Recruiting2028-03Estimated
Pilot Decentralized TrialNCT05419869Alto NeurosciencePhase 2Completed2023-01-13Actual
A Clinical Trial to Evaluate the Safety and Efficacy of Rreproxalap in Adults With Dry Eye DiseaseNCT05424549ALDXPhase 2Completed2022-05-09Actual
Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal CancerNCT05425940ExelixisPhase 3Active not recruiting2026-06-16Actual
A Study of Cytisinicline for Vaping Cessation in Adult SmokersNCT05431387Achieve Life SciencesPhase 2Completed2023-02-28Actual
Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic DermatitisNCT05432596ACRSPhase 2Completed2023-10-26Actual
A Study of the KIO-201 (Ocular Bandage Gel) for Improving Persistent Corneal Epithelial DefectsNCT05436288KPRXPhase 2Completed2022-12-22Actual
Topical SGX302 for Mild-to-Moderate PsoriasisNCT05442190SoligenixPhase 2Completed2025-10-22Actual
A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031)NCT05442775CytokineticsPhase 3Terminated2023-06-07Actual
A Study of ELX-02 in Patients With Alport SyndromeNCT05448755ELOXPhase 2Completed2023-09-11Actual
Berotralstat Treatment in Children With Hereditary AngioedemaNCT05453968BioCryst PharmaceuticalsPhase 3Active not recruiting2024-09-11Actual
Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGDNCT05454956TARSPhase 2Completed2023-05-18Actual
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung AdenocarcinomaNCT05456256LTRNPhase 2Recruiting2026-12Estimated
A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3NCT05461105Hepion Pharmaceuticals, Inc.Phase 2Completed2023-04-15Actual
SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.NCT05461170VIRPhase 2Active not recruiting2031-11Estimated
Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in AdultsNCT05463068NovavaxPhase 3Completed2022-08-17Actual
Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.NCT05463679AYTUPhase 3Suspended2025-06Estimated
MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and HypertriglyceridemiaNCT05464784MediciNovaPhase 2Active not recruiting2026-12-31Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.